EBNK-001 + IL-15 + Pembrolizumab Clinical Trials

1 actively recruiting trial

Also known as: EBNK-001, IL-15, Pembrolizumab

Filter by location:

Other1 trial

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.